Condition
Behcet Disease and Vascular Involvement
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07375940Not ApplicableRecruitingPrimary
Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease
NCT06925698Phase 3Not Yet Recruiting
Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease
NCT06280430Not Yet RecruitingPrimary
Vascular Affection in Behcet Disease
Showing all 3 trials